Structures by: Mavridis I. M.
Total: 16
Complex of (R)(+)2,2'-Dihydroxy-1,1'-binaphthyl with (R)(+)N- (3-Chloro-2-hydroxypropyl)-N,N,N-trimethylammonium Chloride
3X(C20H14O2.C6H15ONCl2)
Organic & biomolecular chemistry (2004) 2, 4 449-451
a=30.941(10)Å b=23.839(7)Å c=10.252(4)Å
α=90.00° β=90.00° γ=90.00°
C134H118B2N6P4Pt2S2,C8H3S2O6,2.5(C3H6NO)
C134H118B2N6P4Pt2S2,C8H3S2O6,2.5(C3H6NO)
Chem.Commun. (2014) 50, 1362
a=26.739(3)Å b=47.581(3)Å c=26.660(3)Å
α=90.00° β=90.00° γ=90.00°
SS-Cyclodextrin/(Z)-7-Tetradecenal complex
C103.6H218.6O92.5
Journal of the Chemical Society, Perkin Transactions 2 (2002) 9 1639
a=15.475(7)Å b=15.466(8)Å c=15.720(4)Å
α=101.86(2)° β=101.91(2)° γ=103.77(3)°
Cyclomaltoheptaose + N,N'-Bis-pyridin-4-ylmethylene-hydrazine inclusion complex
3(C42H70O35),2(C12H10N4),37(H2O)
CrystEngComm (2007) 9, 11 976
a=15.067(10)Å b=15.478(7)Å c=23.36(2)Å
α=101.02(6)° β=99.84(8)° γ=105.10(4)°
Cyclomaltoheptaose + 1-butyl-3-(p-toluenesulfonyl)urea inclusion complex
C47.50H54.16NO44.77S0.50
CrystEngComm (2010) 12, 2 517
a=19.225(11)Å b=24.547(14)Å c=15.708(9)Å
α=90.00° β=109.65(2)° γ=90.00°
Cyclomaltoheptaose + 1-(hexahydro-1H-azepin-1-yl)-3-(p- toluenesulfonyl)urea inclusion complex
C47.13H51.7N1.14O43.62S0.38
CrystEngComm (2010) 12, 2 517
a=18.497(5)Å b=24.186(6)Å c=15.336(6)Å
α=90.00(4)° β=111.13(3)° γ=90.00(3)°
Cyclomaltoheptaose + 3-ethyl-4-methyl-N-(2-(4-((4- methylcyclohexyl)carbamoyl sulfamoyl)phenyl)ethyl) sulfamoyl)phenyl)ethyl)-2-oxo-5H-pyrrole-1-carboxamide inclusion complex
C90.02H91N1.10O89.52S0.22
CrystEngComm (2010) 12, 2 517
a=18.268(9)Å b=15.504(8)Å c=15.428(9)Å
α=102.53(1)° β=113.29(2)° γ=99.97(1)°
B-cyclodextrin + 1,12-dodecanedioic acid complex
2(C42H70O35),C12H22O4,0.51(C2H6O),22.18(H2O1)
Acta Crystallographica Section B (2000) 56, 2 322-331
a=18.220(3)Å b=15.488(3)Å c=15.409(3)Å
α=102.903(6)° β=113.122(5)° γ=99.708(5)°
B-cyclodextrin + 1,12-dodecanedioic acid complex
2(C42H70O35),C12H22O4,1.16(C2H6O),27.46(H2O1)
Acta Crystallographica Section B (2000) 56, 2 322-331
a=18.153(7)Å b=15.456(8)Å c=15.251(4)Å
α=102.81(2)° β=113.130(19)° γ=99.90(3)°
Complex of (S)1,7-Dioxaspiro[5.5]undecane/ Heptakis (2,3,6-tri-Omethyl)-beta-cyclodextrin
C72H129.14O37.57
Acta Crystallographica Section B (2001) 57, 3 399-409
a=10.936(7)Å b=25.53(2)Å c=29.64(4)Å
α=90.00° β=90.00° γ=90.00°
Complex of (R)1,7-Dioxaspiro[5.5]undecane/ Hexakis(2,3,6-tri-O-methyl)-alpha-cyclodextrin
C63H119.65O37.13
Acta Crystallographica Section B (2001) 57, 3 399-409
a=14.636(8)Å b=21.637(10)Å c=23.45(3)Å
α=90.00° β=90.00° γ=90.00°
Beta-Cyclodextrin/ 1,2-bis(4-aminophenyl)ethane complex
C112H127N4O88.08
Acta Crystallographica Section B (2003) 59, 2 287-299
a=19.319(2)Å b=24.190(6)Å c=33.315(7)Å
α=90.000° β=103.924(14)° γ=90.000°
Beta-cyclodextrin/benzidine complex
C108H112N4O94.72
Acta Crystallographica Section B (2003) 59, 2 287-299
a=15.394(7)Å b=31.995(12)Å c=15.621(7)Å
α=90.00° β=103.738(15)° γ=90.00°
Β-Cyclodextrin-nonanoic acid complex
2C42H70O35,1.6C9H18O2,23.9H2O
Acta Crystallographica Section C (1996) 52, 9 2277-2281
a=18.056(3)Å b=15.446(2)Å c=15.452(2)Å
α=103.159(5)° β=112.994(5)° γ=99.352(5)°
Β-Cyclodextrin-Z-9-dodecenol complex
C42H70O35,0.5(C12H24O),9.6(H2O1),0.53(C2H6O1)
Acta Crystallographica Section C (1996) 52, 5 1220-1223
a=19.238(5)Å b=24.477(3)Å c=15.79(2)Å
α=90.00° β=109.52(2)° γ=90.00°
2,4-diamino-5-naphthalen-1-yl-3,5-diaza-1-azoniaspiro[5.5]undeca-1,3-diene Cl
C18H22N5,Cl
Acta Crystallographica Section C (2002) 58, 12 o730-o732
a=24.862(4)Å b=7.3778(14)Å c=19.633(4)Å
α=90° β=101.823(6)° γ=90°